keyword
https://read.qxmd.com/read/38728498/acute-cardiac-tamponade-after-endostar-treatment-of-non-small-cell-lung-cancer-a-case-report
#1
JOURNAL ARTICLE
Wanhui Dong, Mingxing Wang, Pei Zhu, Qingming Sun, Dezhen Wu
RATIONALE: Recombinant human endostatin (Endostar) is extensively utilized in China for the clinical management of patients with driver gene-negative non-small cell lung cancer (NSCLC) at stage TNM IV. This report describes the case of a lung cancer patient treated exclusively with Endostar maintenance therapy, who experienced a rapid deterioration in respiratory function. PATIENT CONCERNS: The case involved a patient with a pathologically confirmed squamous cell carcinoma of the left lung, treated in our department...
May 10, 2024: Medicine (Baltimore)
https://read.qxmd.com/read/38728430/the-biological-and-clinical-impact-of-deletions-before-and-after-large-chromosomal-gains-in-multiple-myeloma
#2
JOURNAL ARTICLE
Anthony M Cirrincione, Alexandra M Poos, Bachisio Ziccheddu, Marcella Kaddoura, Marc-Andrea Baertsch, Kylee H Maclachlan, Monika Chojnacka, Benjamin T Diamond, Lukas John, Philipp Reichert, Stefanie Huhn, Patrick Blaney, Dylan C Gagler, Karsten Rippe, Yanming Zhang, Ahmet Dogan, Alexander M Lesokhin, Faith E Davies, Hartmut Goldschmidt, Roland Fenk, Katja C Weisel, Elias K Mai, Neha Korde, Gareth J Morgan, Saad Z Usmani, Ola Landgren, Marc S Raab, Niels Weinhold, Francesco Maura
Acquisition of a hyperdiploid (HY) karyotype or immunoglobulin heavy chain (IGH) translocations are considered key initiating events in multiple myeloma (MM). To explore if other genomic events can precede these events, we analyzed whole-genome sequencing (WGS) data from 1173 MM samples. Integrating molecular time and structural variants (SV) within early chromosomal duplications, we indeed identified pre-gain deletions in 9.4% of HY patients without IGH translocations, challenging HY as the earliest somatic event...
May 10, 2024: Blood
https://read.qxmd.com/read/38728362/machine-learning-and-multi-omics-data-reveal-driver-gene-based-molecular-subtypes-in-hepatocellular-carcinoma-for-precision-treatment
#3
JOURNAL ARTICLE
Meng Wang, Xinyue Yan, Yanan Dong, Xiaoqin Li, Bin Gao
The heterogeneity of Hepatocellular Carcinoma (HCC) poses a barrier to effective treatment. Stratifying highly heterogeneous HCC into molecular subtypes with similar features is crucial for personalized anti-tumor therapies. Although driver genes play pivotal roles in cancer progression, their potential in HCC subtyping has been largely overlooked. This study aims to utilize driver genes to construct HCC subtype models and unravel their molecular mechanisms. Utilizing a novel computational framework, we expanded the initially identified 96 driver genes to 1192 based on mutational aspects and an additional 233 considering driver dysregulation...
May 10, 2024: PLoS Computational Biology
https://read.qxmd.com/read/38726277/a-signature-of-seven-hypoxia-related-lncrnas-is-a-potential-biomarker-for-predicting-the-prognosis-of-melanoma
#4
JOURNAL ARTICLE
Yunyang Wu, Shenhui Yin, Chunzhen Li, Liyuan Zhao, Mengqi Song, Yizhi Yu, Ling Tang, Yanlong Yang
Melanoma is the most aggressive type of skin cancer and has a high mortality rate once metastasis occurs. Hypoxia is a universal characteristic of the microenvironment of cancer and a driver of melanoma progression. In recent years, long noncoding RNAs (lncRNAs) have attracted widespread attention in oncology research. In this study, screening was performed and revealed seven hypoxia-related lncRNAs AC008687.3, AC009495.1, AC245128.3, AL512363.1, LINC00518, LINC02416 and MCCC1-AS1 as predictive biomarkers. A predictive risk model was constructed via univariate Cox regression analysis, least absolute shrinkage and selection operator (LASSO), and multivariate Cox regression analyses...
2024: American Journal of Cancer Research
https://read.qxmd.com/read/38726051/what-is-driving-the-global-decline-of-human-fertility-need-for-a-multidisciplinary-approach-to-the-underlying-mechanisms
#5
REVIEW
Robert John Aitken
An intense period of human population expansion over the past 250 years is about to cease. Total fertility rates are falling dramatically all over the world such that highly industrialized nations, including China and the tiger economies of SE Asia, will see their populations decline significantly in the coming decades. The socioeconomic, geopolitical and environmental ramifications of this change are considerable and invite a multidisciplinary consideration of the underlying mechanisms. In the short-term, socioeconomic factors, particularly urbanization and delayed childbearing are powerful drivers of reduced fertility...
2024: Front Reprod Health
https://read.qxmd.com/read/38725858/the-dysadherin-fak-axis-promotes-individual-cell-migration-in-colon-cancer
#6
JOURNAL ARTICLE
Choong-Jae Lee, Tae-Young Jang, Jee-Heun Kim, Songwon Lim, Sunjae Lee, Jeong-Seok Nam
Dysregulation of cancer cell motility is a key driver of invasion and metastasis. High dysadherin expression in cancer cells is correlated with invasion and metastasis. Here, we found the molecular mechanism by which dysadherin regulates the migration and invasion of colon cancer (CC). Comprehensive analysis using single-cell RNA sequencing data from CC patients revealed that high dysadherin expression in cells is linked to cell migration-related gene signatures. We confirmed that the deletion of dysadherin in tumor cells hindered local invasion and distant migration using in vivo tumor models...
2024: International Journal of Biological Sciences
https://read.qxmd.com/read/38724705/single-cell-transcriptomic-analyses-reveal-distinct-immune-cell-contributions-to-epithelial-barrier-dysfunction-in-checkpoint-inhibitor-colitis
#7
JOURNAL ARTICLE
Molly Fisher Thomas, Kamil Slowikowski, Kasidet Manakongtreecheep, Pritha Sen, Nandini Samanta, Jessica Tantivit, Mazen Nasrallah, Leyre Zubiri, Neal P Smith, Alice Tirard, Swetha Ramesh, Benjamin Y Arnold, Linda T Nieman, Jonathan H Chen, Thomas Eisenhaure, Karin Pelka, Yuhui Song, Katherine H Xu, Vjola Jorgji, Christopher J Pinto, Tatyana Sharova, Rachel Glasser, PuiYee Chan, Ryan J Sullivan, Hamed Khalili, Dejan Juric, Genevieve M Boland, Michael Dougan, Nir Hacohen, Bo Li, Kerry L Reynolds, Alexandra-Chloé Villani
Immune checkpoint inhibitor (ICI) therapy has revolutionized oncology, but treatments are limited by immune-related adverse events, including checkpoint inhibitor colitis (irColitis). Little is understood about the pathogenic mechanisms driving irColitis, which does not readily occur in model organisms, such as mice. To define molecular drivers of irColitis, we used single-cell multi-omics to profile approximately 300,000 cells from the colon mucosa and blood of 13 patients with cancer who developed irColitis (nine on anti-PD-1 or anti-CTLA-4 monotherapy and four on dual ICI therapy; most patients had skin or lung cancer), eight controls on ICI therapy and eight healthy controls...
May 9, 2024: Nature Medicine
https://read.qxmd.com/read/38723776/tracing-tumor-heterogeneity-of-pleomorphic-carcinoma-of-the-lung
#8
JOURNAL ARTICLE
Luca Roma, Caner Ercan, Floriana Conticelli, Nalan Akyürek, Spasenija Savic Prince, Kirsten D Mertz, Joachim Diebold, Didier Lardinois, Salvatore Piscuoglio, Charlotte Ky Ng, Lukas Bubendorf
BACKGROUND: Pulmonary pleomorphic carcinoma (PPC) is an aggressive and highly heterogeneous non-small-cell lung carcinoma whose underlying biology is still poorly understood. METHODS: Forty-two tumor areas from 20 PPC patients were microdissected, including 39 primary tumors and 3 metastases and the histologically distinct components were subjected to whole exome sequencing (WES) separately. We further performed in silico analysis of microdissected bulk RNAseq and methylation data of 28 samples from 14 PPC patients...
May 7, 2024: Journal of Thoracic Oncology
https://read.qxmd.com/read/38722595/identification-of-clonal-hematopoiesis-driver-mutations-through-in-silico-saturation-mutagenesis
#9
JOURNAL ARTICLE
Santiago Demajo, Joan Enric Ramis-Zaldivar, Ferran Muinos, Miguel L Grau, Maria Andrianova, Nuria Lopez-Bigas, Abel Gonzalez-Perez
Clonal hematopoiesis (CH) is a phenomenon of clonal expansion of hematopoietic stem cells driven by somatic mutations affecting certain genes. Recently, CH has been linked to the development of hematologic malignancies, cardiovascular diseases, and other conditions. Although the most frequently mutated CH driver genes have been identified, a systematic landscape of the mutations capable of initiating this phenomenon is still lacking. Here, we trained machine-learning models for 12 of the most recurrent CH genes to identify their driver mutations...
May 9, 2024: Cancer Discovery
https://read.qxmd.com/read/38722224/genomic-profiling-of-pleomorphic-rhabdomyosarcoma-reveals-a-genomic-signature-distinct-from-that-of-embryonal-rhabdomyosarcoma
#10
JOURNAL ARTICLE
Carla Saoud, Josephine K Dermawan, Aarti E Sharma, William Tap, Leonard H Wexler, Cristina R Antonescu
Pleomorphic rhabdomyosarcoma (PRMS) is a rare and highly aggressive sarcoma, occurring mostly in the deep soft tissues of middle-aged adults and showing a variable degree of skeletal muscle differentiation. The diagnosis is challenging as pathologic features overlap with embryonal rhabdomyosarcoma (ERMS), malignant Triton tumor, and other pleomorphic sarcomas. As recurrent genetic alterations underlying PRMS have not been described to date, ancillary molecular diagnostic testing is not useful in subclassification...
May 2024: Genes, Chromosomes & Cancer
https://read.qxmd.com/read/38721669/functional-exploration-of-copy-number-alterations-in-a-drosophila-model-of-triple-negative-breast-cancer
#11
JOURNAL ARTICLE
Jennifer E L Diaz, Vanessa Barcessat, Christian Bahamon, Chana Hecht, Tirtha K Das, Ross L Cagan
Accounting for 10-20% of breast cancer cases, TNBC is associated with a disproportionate number of breast cancer deaths. One challenge in studying TNBC is its genomic profile: outside of TP53 loss, most cases are characterized by copy number alterations (CNAs), making modeling the disease in whole animals challenging. We computationally analyzed 186 previously identified CNA regions in breast cancer to rank genes within each region by likelihood of acting as a tumor driver. We then used a Drosophila p53-Myc TNBC model to identify 48 genes as functional drivers...
May 9, 2024: Disease Models & Mechanisms
https://read.qxmd.com/read/38719881/hyperthyroidism-driven-bone-loss-depends-on-bmp-receptor-bmpr1a-expression-in-osteoblasts
#12
JOURNAL ARTICLE
Franziska Lademann, Eddy Rijntjes, Josef Köhrle, Elena Tsourdi, Lorenz C Hofbauer, Martina Rauner
Hyperthyroidism is a well-known trigger of high bone turnover that can lead to the development of secondary osteoporosis. Previously, we have shown that blocking bone morphogenetic protein (BMP) signaling systemically with BMPR1A-Fc can prevent bone loss in hyperthyroid mice. To distinguish between bone cell type-specific effects, conditional knockout mice lacking Bmpr1a in either osteoclast precursors (LysM-Cre) or osteoprogenitors (Osx-Cre) were rendered hyperthyroid and their bone microarchitecture, strength and turnover were analyzed...
May 8, 2024: Communications Biology
https://read.qxmd.com/read/38719469/estrogen-receptor-1-chromatin-profiling-in-human-breast-tumors-reveals-high-inter-patient-heterogeneity-with-enrichment-of-risk-snps-and-enhancer-activity-at-most-conserved-regions
#13
JOURNAL ARTICLE
Stacey E P Joosten, Sebastian Gregoricchio, Suzan Stelloo, Elif Yapıcı, Chia-Chi Flora Huang, Kerim Yavuz, Maria Donaldson Collier, Tunç Morova, Umut Berkay Altintaş, Yongsoo Kim, Sander Canisius, Cathy B Moelans, Paul J van Diest, Gozde Korkmaz, Nathan A Lack, Michiel Vermeulen, Sabine C Linn, Wilbert Zwart
Estrogen Receptor 1 (ESR1; also known as ERα, encoded by ESR1 gene) is the main driver and prime drug target in luminal breast cancer. ESR1 chromatin binding is extensively studied in cell lines and a limited number of human tumors, using consensi of peaks shared among samples. However, little is known about inter-tumor heterogeneity of ESR1 chromatin action, along with its biological implications. Here, we use a large set of ESR1 ChIP-seq data from 70 ESR1+ breast cancers to explore inter-patient heterogeneity in ESR1 DNA binding to reveal a striking inter-tumor heterogeneity of ESR1 action...
May 6, 2024: Genome Research
https://read.qxmd.com/read/38718214/prevalence-and-clinicopathological-features-of-driver-gene-mutations-profile-in-bcr-abl1-negative-classical-myeloproliferative-neoplasm-a-single-center-study-from-north-india
#14
JOURNAL ARTICLE
Khaliqur Rahman, Seema Biswas, Akhilesh Sharma, Kusum Gupta, Dinesh Chandra, Manish K Singh, Ruchi Gupta, Ashish Mishra, Sanjeev Kumar, Anshul Gupta, Faheema Hasan, Soniya Nityanand, Rajesh Kahsyap
BACKGROUND: Recurrent somatic mutations in the JAK2, CALR, and the MPL genes are noted in BCR: ABL1 negative classic myeloproliferative neoplasms (MPN) that includes polycythemia vera (PV), essential thrombocytosis (ET), and primary myelofibrosis (PMF). MATERIALS AND METHODS: Mutation profile and clinical features of MPN cases diagnosed at a tertiary care center in North India are being described. JAK2V617F mutation was screened using ARMS PCR, and CALR mutation was screened using allele-specific PCR followed by fragment analysis...
March 25, 2024: Indian Journal of Pathology & Microbiology
https://read.qxmd.com/read/38718076/long-non-coding-rna-msl3p1-regulates-cul3-mrna-cytoplasmic-transport-and-stability-and-promotes-lung-adenocarcinoma-metastasis
#15
JOURNAL ARTICLE
Ming-Ming Shao, Xin Li, Rui-Qi Wei, Qing-Yu Chen, Xin Zhang, Xin Qiao, Hui Li
Lung adenocarcinoma (LUAD) is the most prevalent histological type of lung cancer. Previous studies have reported that specific long non-coding RNAs (lncRNAs) are involved in cancer development and progression. The phenotype and mechanism of ENST00000440028, named MSL3P1, a lncRNA which we referring to a cancer-testis gene with potential roles in tumorigenesis and progression, have not been reported. We found that MSL3P1 is overexpressed in LUAD tumor tissues, which is significantly associated with clinical characteristics, metastasis, and poor clinical prognosis...
May 8, 2024: Molecular Cancer Research: MCR
https://read.qxmd.com/read/38717941/macroevolutionary-dynamics-in-micro-organisms-generalists-give-rise-to-specialists-across-biomes-in-the-ubiquitous-bacterial-phylum-myxococcota
#16
JOURNAL ARTICLE
Daniel Padfield, Suzanne Kay, Rutger Vos, Christopher Quince, Michiel Vos
Prokaryotes dominate the Tree of Life, but our understanding of the macroevolutionary processes generating this diversity is still limited. Habitat transitions are thought to be a key driver of prokaryote diversity. However, relatively little is known about how prokaryotes successfully transition and persist across environments, and how these processes might vary between biomes and lineages. Here, we investigate biome transitions and specialisation in natural populations of a focal bacterial phylum, the Myxococcota, sampled across a range of replicated soils and freshwater and marine sediments in Cornwall (UK)...
May 8, 2024: Molecular Biology and Evolution
https://read.qxmd.com/read/38717857/dna-lesion-bypass-and-the-stochastic-dynamics-of-transcription-coupled-repair
#17
JOURNAL ARTICLE
Michael D Nicholson, Craig J Anderson, Duncan T Odom, Sarah J Aitken, Martin S Taylor
DNA base damage is a major source of oncogenic mutations and disruption to gene expression. The stalling of RNA polymerase II (RNAP) at sites of DNA damage and the subsequent triggering of repair processes have major roles in shaping the genome-wide distribution of mutations, clearing barriers to transcription, and minimizing the production of miscoded gene products. Despite its importance for genetic integrity, key mechanistic features of this transcription-coupled repair (TCR) process are controversial or unknown...
May 14, 2024: Proceedings of the National Academy of Sciences of the United States of America
https://read.qxmd.com/read/38717453/cell-type-and-transcription-independent-spatial-proximity-between-enhancers-and-promoters
#18
JOURNAL ARTICLE
Yasmine Mian, Li Wang, Adib Keikhosravi, Konnie Guo, Tom Misteli, H Efsun Arda, Elizabeth H Finn
Cell type-specific enhancers are critically important for lineage specification. The mechanisms that determine cell type-specificity of enhancer activity, however, are not fully understood. Most current models for how enhancers function invoke physical proximity between enhancer elements and their target genes. Here, we use an imaging-based approach to examine the spatial relationship of cell type-specific enhancers and their target genes with single cell resolution. Using high-throughput microscopy, we measure the spatial distance from target promoters to their cell type-specific active and inactive enhancers in individual pancreatic cells derived from distinct lineages...
May 8, 2024: Molecular Biology of the Cell
https://read.qxmd.com/read/38717196/lack-of-physiological-evidence-for-cytochrome-filaments-functioning-as-conduits-for-extracellular-electron-transfer
#19
JOURNAL ARTICLE
Ingrid A Schwarz, Baha Alsaqri, Yassir Lekbach, Kathryn Henry, Sydney Gorman, Trevor Woodard, Laura Dion, Lauren Real, Dawn E Holmes, Jessica A Smith, Derek R Lovley
UNLABELLED: Extracellular cytochrome filaments are proposed to serve as conduits for long-range extracellular electron transfer. The primary functional physiological evidence has been the reported inhibition of Geobacter sulfurreducens Fe(III) oxide reduction when the gene for the filament-forming cytochrome OmcS is deleted. Here we report that the OmcS-deficient strain from that original report reduces Fe(III) oxide as well as the wild-type, as does a triple mutant in which the genes for the other known filament-forming cytochromes were also deleted...
May 8, 2024: MBio
https://read.qxmd.com/read/38716727/circadian-transcriptome-of-pancreatic-adenocarcinoma-unravels-chronotherapeutic-targets
#20
JOURNAL ARTICLE
Deepak Sharma, Darbaz Adnan, Mostafa K Abdel-Reheem, Ron C Anafi, Daniel D Leary, Faraz Bishehsari
Pancreatic ductal adenocarcinoma (PDA) is a lethal cancer characterized by a poor outcome and an increasing incidence. A significant majority (>80%) of newly diagnosed cases are deemed unresectable, leaving chemotherapy as the sole viable option, though with only moderate success. This necessitates the identification of improved therapeutic options for PDA. We hypothesized that there are temporal variations in cancer-relevant processes within PDA tumors, offering insights into the optimal timing of drug administration - a concept termed chronotherapy...
May 8, 2024: JCI Insight
keyword
keyword
110602
1
2
Fetch more papers »
Fetching more papers... Fetching...
Remove bar
Read by QxMD icon Read
×

Save your favorite articles in one place with a free QxMD account.

×

Search Tips

Use Boolean operators: AND/OR

diabetic AND foot
diabetes OR diabetic

Exclude a word using the 'minus' sign

Virchow -triad

Use Parentheses

water AND (cup OR glass)

Add an asterisk (*) at end of a word to include word stems

Neuro* will search for Neurology, Neuroscientist, Neurological, and so on

Use quotes to search for an exact phrase

"primary prevention of cancer"
(heart or cardiac or cardio*) AND arrest -"American Heart Association"

We want to hear from doctors like you!

Take a second to answer a survey question.